IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDY

IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDY

Objective: to investigate the immunogenicity, safety, and clinical efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with rheumatoid arthritis (RA) during a two-year follow-up study.Subjects and methods. The prospective open-label comparative study enrolled 110 people, of them th...

Full description

Bibliographic Details
Main Authors: M. S. Naumtseva, B. S. Belov, E. N. Aleksandrova, G. M. Tarasova, A. A. Novikov, D. E. Karateev, E. L. Luchikhina, M. V. Cherkasova, Yu. V. Muravyev
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2017-01-01
Series:Научно-практическая ревматология
Subjects:
rheumatoid arthritis
autoimmune diseases
pneumonia
bronchitis
pneumococcal vaccine
vaccination
comorbid infections
comorbidity
immunogenicity
efficacy
tolerability
Online Access:https://rsp.mediar-press.net/rsp/article/view/2322

Internet

https://rsp.mediar-press.net/rsp/article/view/2322

Similar Items